The Global Allergic Rhinitis Drugs Market will reach $11bn in 2015 according to new Visiongain report

LONDON - Nov. 24, 2015 - PRLog -- PRESS RELEASE: “THE GLOBAL ALLERGIC RHINITIS DRUGS MARKET WILL REACH $11BN IN 2015 ACCORDING TO NEW VISIONGAIN REPORT”

A new report by visiongain calculates that the global allergic rhinitis drugs market will reach $11bn in 2015 with revenues showing growth to 2025. These revenue forecasts and others appear in visiongain’s latest report Allergic Rhinitis Drugs Market Forecast 2015-2025: Future Prospects for Companies in Antihistamines, Corticosteroids, Immunotherapy & Vaccines. Visiongain is a leading market intelligence company based in London, UK.

The market for allergic rhinitis drugs is comprised of a large number of companies marketing drugs for wide range of indications. Many of the leading drugs in this market are losing marketing exclusivity in major markets and are being subjected to intense generic drug competition. Furthermore, the many Rx-OTC switches taking place within this sector of the pharma industry will continue to add to the complexities of the market.

Moses Akintomide-Akinwamide, a senior pharmaceutical and medical technology market analyst at Visiongain explains: “The allergic rhinitis drugs market has faced generic competition over the last few years, particularly for some of the leading products within the market. Despite this, the market has experienced growth. We expect the rising prevalence and improving access to healthcare to contribute to market growth. The advantage that immunotherapies have over intranasal drugs is their potential to provide long-term prevention of symptoms and this will significantly boost sales growth within this segment of the market.”

Visiongain’s report provides revenue forecasts to 2025 for the global allergic rhinitis drugs market and its leading regional and national markets. It forecast sales in the US, EU5 (Germany, Spain, Italy, UK, and France), India, Japan, China, Brazil, Russia, and Mexico. The report also forecasts sales by value and by volume for individual segments of the allergic rhinitis drugs market. These include the intranasal corticosteroids, oral antihistamines, immunotherapies & vaccines, and the intranasal antihistamines segments of the market. Analysis and forecasts for key marketed products in each of these segments are provided together with profiles, analyses, and forecasts of products in the development pipeline. Visiongain also forecasts sales by value and volume for various classes of generic intranasal corticosteroids and generic intranasal antihistamines.

Analyses and evaluation of historical revenue and business operations of 8 leading companies within the market are also provided together with evaluation of their future potential. The allergic rhinitis drug revenues for these companies are also forecasted from 2015 to 2025. The report includes analyses of strengths, weaknesses, opportunities, and threats to the market, as well as a Porter’s five forces analyses examining the powers of suppliers and buyers, the threat of substitutes and new entrants, and the rivalry amongst competitors in the market. Transcript of interviews with key opinion leaders in the industry sharing their views on current market trends and the unmet needs in the market are also included in the report.

Allergic Rhinitis Drugs Market Forecast 2015-2025: Future Prospects for Companies in Antihistamines, Corticosteroids, Immunotherapy & Vaccines adds to visiongain’s extensive range of analytical reports on industries and markets in healthcare.

For an executive summary please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com

Tel: +44 (0) 20 7336 6100

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain

Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.